| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
20,847 |
19,602 |
$2.77M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
20,010 |
18,232 |
$2.59M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
28,833 |
24,910 |
$2.38M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,106 |
5,034 |
$1.69M |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,599 |
2,317 |
$698K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,154 |
1,969 |
$610K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,951 |
5,354 |
$603K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,522 |
1,308 |
$498K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,997 |
3,816 |
$464K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
3,216 |
3,120 |
$359K |
| 0240U |
|
2,557 |
2,365 |
$335K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,657 |
2,417 |
$328K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,599 |
2,181 |
$289K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,052 |
705 |
$275K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
701 |
609 |
$251K |
| 97597 |
|
2,589 |
1,325 |
$247K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,222 |
752 |
$202K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
2,070 |
833 |
$200K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
2,011 |
741 |
$190K |
| 20610 |
|
1,187 |
1,062 |
$165K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
650 |
560 |
$157K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
369 |
342 |
$126K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
22,900 |
19,350 |
$113K |
| 84484 |
|
16,270 |
9,443 |
$46K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
655 |
384 |
$40K |
| 71250 |
|
699 |
635 |
$33K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
443 |
221 |
$31K |
| G0378 |
Hospital observation service, per hour |
898 |
582 |
$30K |
| 80053 |
Comprehensive metabolic panel |
5,763 |
5,095 |
$29K |
| 97161 |
|
253 |
244 |
$24K |
| 80076 |
|
10,338 |
9,336 |
$24K |
| 96368 |
|
301 |
206 |
$23K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
258 |
91 |
$16K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
526 |
475 |
$14K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
29,820 |
25,397 |
$14K |
| 71045 |
Radiologic examination, chest; single view |
9,028 |
8,038 |
$14K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
120 |
97 |
$12K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
14,364 |
12,786 |
$11K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
685 |
605 |
$10K |
| 96367 |
|
198 |
150 |
$10K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
55 |
54 |
$9K |
| 83605 |
|
5,138 |
3,471 |
$8K |
| 70486 |
|
99 |
95 |
$8K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,707 |
1,548 |
$8K |
| 80320 |
|
360 |
301 |
$7K |
| 97162 |
|
125 |
119 |
$7K |
| 12001 |
|
39 |
39 |
$6K |
| 36415 |
Collection of venous blood by venipuncture |
27,463 |
22,989 |
$6K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
29 |
28 |
$6K |
| 71046 |
Radiologic examination, chest; 2 views |
1,163 |
1,078 |
$5K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
60 |
52 |
$5K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
69 |
40 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,662 |
4,579 |
$5K |
| 73630 |
|
432 |
384 |
$4K |
| 73562 |
|
381 |
333 |
$4K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
29 |
26 |
$3K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
13 |
13 |
$3K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,601 |
7,721 |
$3K |
| 73610 |
|
349 |
305 |
$3K |
| 11721 |
|
190 |
176 |
$3K |
| 87040 |
|
3,173 |
1,513 |
$3K |
| 81001 |
|
12,875 |
11,756 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,439 |
3,602 |
$2K |
| 73030 |
|
229 |
212 |
$2K |
| 96376 |
|
944 |
637 |
$2K |
| 97166 |
|
29 |
28 |
$2K |
| 94664 |
|
1,271 |
995 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
780 |
734 |
$2K |
| 90715 |
|
105 |
96 |
$2K |
| 73110 |
|
130 |
115 |
$2K |
| 73130 |
|
203 |
190 |
$2K |
| 82962 |
|
2,345 |
807 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
200 |
176 |
$2K |
| 85610 |
|
7,144 |
6,361 |
$1K |
| 99406 |
|
147 |
134 |
$1K |
| 93971 |
|
12 |
12 |
$1K |
| 86140 |
|
2,920 |
2,610 |
$1K |
| 80061 |
Lipid panel |
93 |
87 |
$1K |
| 83690 |
|
5,359 |
4,699 |
$1K |
| 93922 |
|
14 |
13 |
$1K |
| J3490 |
Unclassified drugs |
147 |
116 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,727 |
1,566 |
$1K |
| 85730 |
|
6,942 |
6,070 |
$1K |
| 83880 |
|
1,733 |
1,530 |
$966.51 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,474 |
1,237 |
$950.97 |
| 81025 |
|
2,151 |
1,940 |
$700.40 |
| 82803 |
|
1,101 |
736 |
$692.22 |
| 80306 |
|
636 |
555 |
$589.49 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
640 |
599 |
$552.82 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
42 |
41 |
$550.03 |
| 84702 |
|
91 |
77 |
$539.37 |
| 82553 |
|
76 |
39 |
$537.18 |
| 87420 |
|
18 |
17 |
$528.66 |
| 94660 |
|
16 |
12 |
$521.58 |
| 83735 |
|
1,641 |
1,432 |
$492.80 |
| 85379 |
|
740 |
641 |
$470.01 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
28 |
27 |
$456.42 |
| 90686 |
|
64 |
60 |
$450.26 |
| 81003 |
|
1,196 |
1,086 |
$443.06 |
| 86900 |
|
17 |
14 |
$387.61 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,067 |
786 |
$372.33 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,525 |
3,047 |
$360.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,388 |
3,855 |
$358.01 |
| 82150 |
|
809 |
735 |
$343.89 |
| 82140 |
|
190 |
160 |
$328.71 |
| 73502 |
|
19 |
13 |
$323.61 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
77 |
70 |
$282.24 |
| 87186 |
|
812 |
587 |
$198.80 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
243 |
227 |
$194.37 |
| 87077 |
|
819 |
592 |
$181.77 |
| 85652 |
|
158 |
146 |
$173.36 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,263 |
2,389 |
$171.62 |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,753 |
1,130 |
$171.32 |
| 36600 |
|
201 |
142 |
$169.96 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
593 |
419 |
$164.45 |
| 82550 |
|
76 |
39 |
$138.61 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,471 |
1,353 |
$110.70 |
| 82375 |
|
375 |
247 |
$108.93 |
| 84703 |
|
116 |
92 |
$102.80 |
| 84100 |
|
115 |
111 |
$98.27 |
| 85018 |
|
333 |
235 |
$94.92 |
| 87340 |
|
13 |
13 |
$89.51 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
468 |
362 |
$88.91 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,618 |
3,847 |
$65.34 |
| 80329 |
|
216 |
180 |
$62.48 |
| 86709 |
|
13 |
13 |
$61.14 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
697 |
562 |
$43.88 |
| 82607 |
|
28 |
26 |
$42.88 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
68 |
59 |
$42.56 |
| 84439 |
|
13 |
12 |
$36.82 |
| 82746 |
|
27 |
25 |
$30.56 |
| 86803 |
|
13 |
13 |
$30.56 |
| 86706 |
|
13 |
13 |
$30.56 |
| 86704 |
|
13 |
13 |
$30.56 |
| J2060 |
Injection, lorazepam, 2 mg |
277 |
217 |
$28.28 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
202 |
153 |
$25.68 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
511 |
365 |
$24.47 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
55 |
54 |
$23.18 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
49 |
38 |
$19.11 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
342 |
250 |
$13.24 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
112 |
92 |
$10.12 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
36 |
23 |
$6.73 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
223 |
199 |
$4.65 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
324 |
255 |
$2.81 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
202 |
186 |
$0.54 |
| 84145 |
|
37 |
27 |
$0.00 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
16 |
12 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
36 |
25 |
$0.00 |
| 73590 |
|
16 |
12 |
$0.00 |
| A9270 |
Non-covered item or service |
835 |
494 |
$0.00 |
| 94760 |
|
272 |
148 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
132 |
121 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
95 |
89 |
$0.00 |
| 86901 |
|
17 |
14 |
$0.00 |